Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Adaptimmune Therapeutics plc (ADAP)

10.44 -0.54 (-4.92%)

07-20 16:00

Open:

10.93

Pre. Close:

10.98

High:

10.9545

Low:

10.36

Volume:

532,443

Market Cap:

986M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

10.962 - 11.051

11.051 - 11.111

Low:

10.18 - 10.276

10.276 - 10.34

Close:

10.315 - 10.463

10.463 - 10.562

Technical analysis  (as of: 2018-07-20 4:35:50 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 14.26     One year: 15.59

Support:

Support1: 10.36    Support2: 8.62

Resistance:

Resistance1: 12.21    Resistance2: 13.35

Pivot:

11.27

Moving Averages:

MA(5): 10.98     MA(20): 11.59

MA(100): 11.69     MA(250): 9.16

MACD:

MACD(12,26): -0.43     Signal(12,26,9): -0.37

%K %D:

%K(14,3): 16.08     %D(3): 21.63

RSI:

RSI(14): 32.50

52-Week:

High: 14.625  Low: 4.82  Change(%): 83.8

Average Vol(K):

3-Month: 39522  10-Days 41732

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ADAP has closed below the lower band by 5.7%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 31.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-07-18T08:57:26-04:00
Adaptimmune's SPEAR cells pass safety review in NSCLC study; dose to be raised; shares up 1% premarket

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

94.14

Shares Float (M)

61.80

% Held by Insiders

34.40

% Held by Institutions

Shares Short (K)

2193

Shares Short Prior Month (K)

Stock Financials

EPS

-0.770

EPS Est. Current Year

-0.990

EPS Est. Next Year

EPS Est. Next Quarter

-0.250

Forward EPS

-1.310

Book Value (p.s.)

5.450

PEG Ratio

-0.98

Profit Margin

Operating Margin

-201.94

Return on Assets (ttm)

-27.1

Return on Equity (ttm)

-34.8

Qtrly Rev. Growth

186.9

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.192

Qtrly Earnings Growth

Operating Cash Flow (M)

-73.16

Levered Free Cash Flow (M)

-44.43

atoplab.com

Valuation

P/E

-13.56

P/E Growth Ratio

-0.05

P/BV

1.92

P/S

2136568704.00

P/CF

-13.43

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2018-03-30

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.